Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatu Pantsar

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Cells|April 23, 2022
Target Hopping from Protein Kinases to PXR: Identification of Small-Molecule Protein Kinase Inhibitors as Selective Modulators of Pregnane X Receptor from TüKIC LibraryEnni-Kaisa Mustonen, Tatu Pantsar, Azam Rashidian, et al.
Computational and Structural Biotechnology Journal|July 5, 2022
Discrepancy in interactions and conformational dynamics of pregnane X receptor (PXR) bound to an agonist and a novel competitive antagonistAzam Rashidian, Enni-Kaisa Mustonen, Thales Kronenberger, et al.
Molecules (Basel, Switzerland)|June 28, 2019
Design, Synthesis and Biological Evaluation of 7-Chloro-9<i>H</i>-pyrimido[4,5-<i>b</i>]indole-based Glycogen Synthase Kinase-3β InhibitorsStanislav Andreev, Tatu Pantsar, Francesco Ansideri, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 13, 2018
The use of molecular descriptors in the development of co-amorphous formulationsHelena Meng-Lund, Georgia Kasten, Katrine Tarp Jensen, et al.
European Journal of Medicinal Chemistry|October 23, 2020
Design and synthesis of novel fluorescently labeled analogs of vemurafenib targeting MKK4Theresa Kircher, Tatu Pantsar, Andreas Oder, et al.
Journal of Medicinal Chemistry|May 29, 2020
Bioisosteric Replacement of Arylamide-Linked Spine Residues with <i>N</i>-Acylhydrazones and Selenophenes as a Design Strategy to Novel Dibenzosuberone Derivatives as Type I 1/2 p38α MAP Kinase InhibitorsJúlia G B Pedreira, Philipp Nahidino, Mark Kudolo, et al.
Bioorganic Chemistry|June 5, 2024
Bromo-substituted indirubins for inhibition of protein kinase-mediated signalling involved in inflammatory mediator release in human monocytesVivien Bachmann, Patrick Schädel, Jan Westhoff, et al.
European Journal of Medicinal Chemistry|May 17, 2019
Pyridinylimidazoles as dual glycogen synthase kinase 3β/p38α mitogen-activated protein kinase inhibitorsFabian Heider, Francesco Ansideri, Roberta Tesch, et al.
Molecular Pharmacology|December 26, 2013
Mutation of Cys242 of human monoacylglycerol lipase disrupts balanced hydrolysis of 1- and 2-monoacylglycerols and selectively impairs inhibitor potencyTuomo Laitinen, Dina Navia-Paldanius, Roosa Rytilahti, et al.
Molecular Pharmacology|August 21, 2014
Robust hydrolysis of prostaglandin glycerol esters by human monoacylglycerol lipase (MAGL)Juha R Savinainen, Emilia Kansanen, Tatu Pantsar, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Cells|April 23, 2022
Target Hopping from Protein Kinases to PXR: Identification of Small-Molecule Protein Kinase Inhibitors as Selective Modulators of Pregnane X Receptor from TüKIC LibraryEnni-Kaisa Mustonen, Tatu Pantsar, Azam Rashidian, et al.
Computational and Structural Biotechnology Journal|July 5, 2022
Discrepancy in interactions and conformational dynamics of pregnane X receptor (PXR) bound to an agonist and a novel competitive antagonistAzam Rashidian, Enni-Kaisa Mustonen, Thales Kronenberger, et al.
Molecules (Basel, Switzerland)|June 28, 2019
Design, Synthesis and Biological Evaluation of 7-Chloro-9<i>H</i>-pyrimido[4,5-<i>b</i>]indole-based Glycogen Synthase Kinase-3β InhibitorsStanislav Andreev, Tatu Pantsar, Francesco Ansideri, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 13, 2018
The use of molecular descriptors in the development of co-amorphous formulationsHelena Meng-Lund, Georgia Kasten, Katrine Tarp Jensen, et al.
European Journal of Medicinal Chemistry|October 23, 2020
Design and synthesis of novel fluorescently labeled analogs of vemurafenib targeting MKK4Theresa Kircher, Tatu Pantsar, Andreas Oder, et al.
Journal of Medicinal Chemistry|May 29, 2020
Bioisosteric Replacement of Arylamide-Linked Spine Residues with <i>N</i>-Acylhydrazones and Selenophenes as a Design Strategy to Novel Dibenzosuberone Derivatives as Type I 1/2 p38α MAP Kinase InhibitorsJúlia G B Pedreira, Philipp Nahidino, Mark Kudolo, et al.
Bioorganic Chemistry|June 5, 2024
Bromo-substituted indirubins for inhibition of protein kinase-mediated signalling involved in inflammatory mediator release in human monocytesVivien Bachmann, Patrick Schädel, Jan Westhoff, et al.
European Journal of Medicinal Chemistry|May 17, 2019
Pyridinylimidazoles as dual glycogen synthase kinase 3β/p38α mitogen-activated protein kinase inhibitorsFabian Heider, Francesco Ansideri, Roberta Tesch, et al.
Molecular Pharmacology|December 26, 2013
Mutation of Cys242 of human monoacylglycerol lipase disrupts balanced hydrolysis of 1- and 2-monoacylglycerols and selectively impairs inhibitor potencyTuomo Laitinen, Dina Navia-Paldanius, Roosa Rytilahti, et al.
Molecular Pharmacology|August 21, 2014
Robust hydrolysis of prostaglandin glycerol esters by human monoacylglycerol lipase (MAGL)Juha R Savinainen, Emilia Kansanen, Tatu Pantsar, et al.
Pageof 4